The International Pharmaceutical Federation IFPMA represents patients, doctors, pharmacists and other interested parties since today's Internet search engine for clinical trials in German ready. Launched in English in the fall of 2005, the site offers two different ways to search for clinical trials to test medications:
- Ongoing clinical trials
The information on ongoing clinical trials in addition to information on the study drug and its indication and contact information for doctors and patients, if they wish to participate in the study.
- Results of completed studies
The information on completed studies in addition to information on the drug and its indication, a summary of the study results.
The portal is related to the commitment of the research-based pharmaceutical companies, according to clinical trial information should be accessible to everyone. The drug company had committed itself to register ongoing trials and beyond to publish the results of studies, which are available to authorized medicinal products. As appropriate publications partially present in different databases and different Internet servers, the IFPMA has now created with the portal a convenient solution that scans all systems simultaneously and provides the user with a common search result.
When searching is also possible to search within a particular country ongoing studies.
The search functions are available immediately, except in German, in French, Spanish and Japanese. However, results are (mostly English) issued in the original recorded language.
The VFA has published on its website for some time, in which databases its member companies clinical trials and publish test results (see: ).
Search IFPMA Clinical Trials Portal:
Finding the Evidence: A Gateway to the Literature in Child and Adolescent Mental Health
Book (Amer Psychiatric Pub)
OT Toxic Psychiatry2012-12-13 22:22:18 by Masters_apprentice
As Dr. Peter Breggin describes it in his landmark book, Toxic Psychiatry, a deal was struck. Drug companies would bankroll psychiatry and rescue it. These companies would pour money into professional conferences, journals, research. In return, they wanted science that would promote mental disease as a biological fact, a gateway into the drugs. Everyone would winexcept the patient.
So the studies were rolled out, and the list of mental disorders expanded. The FDA was in on the deal as well, as evidenced by their drug approvals, in the face of the obvious damage these drugs were doing
You might also like:
Foreign companies stop clinical trials in India after government amends rules .. — Times of India
Patients who participate in a clinical trial receive greater degree of medical care than they would have under regular treatment because of the high level of investigations and patient management that a clinical study protocol requires,'' Thatte said ..
HealthGrid Applications and Technologies Meet Science Gateways for Life Sciences (Studies in Health Technology and Informatics)
Book (IOS Press)